Skip to content

The Effect on Attendance of an SMS Notification Prior to a Scheduled Screening Appointment in BreastScreen Norway

Sending SMS Notification Prior to a Scheduled Screening Appointment in BreastScreen Norway - the Effect on Attendance

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07355569
Enrollment
133770
Registered
2026-01-21
Start date
2025-01-10
Completion date
2025-10-31
Last updated
2026-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attendance, Breast Cancer Screening

Keywords

breast cancer screening, SMS notification, attendance

Brief summary

This study has been designed as a randomized controlled trial including women invited to a national screening program for breast cancer in Norway, BreastScreen Norway in 2025. The program invites women aged 50-69 to biennial screening mammography. The study includes two substudies with the intervention of sending an SMS notification three days prior to the screening appointment in the first substudy and two days prior to the screening appointment in second study. The comparison is made between the study groups, where women are sent an SMS notification two or three days prior to their scheduled screening appointment and the control groups where women will not be sent an SMS notification about a scheduled screening appointment.

Interventions

Available in the NCCR and sent an SMS notification three or two days prior to a scheduled screening appointment

Sponsors

Norwegian Institute of Public Health
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE

Intervention model description

Simple 1:1 randomization

Eligibility

Sex/Gender
FEMALE
Age
50 Years to 71 Years
Healthy volunteers
Yes

Inclusion criteria

* women invited to BreastScreen Norway residing in the South-Eastern, Central, and Northern Norway Regional Health Authorities

Exclusion criteria

* no

Design outcomes

Primary

MeasureTime frameDescription
Screening attendanceThree months (180 days) after scheduled date for a screening examination following a routine invitation or three months (180 days) after a reminder was posted.Attendance after a routine or reminder invitation, with and without an SMS notification

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026